Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer

Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer

<b>Background:</b> Bladder cancer (BLCA) is highly heterogeneous with distinct molecular subtypes. This research aimed to investigate the heterogeneity of different molecular subtypes from a tumor microenvironment perspective and develop a molecular-subtype-associated immune prognostic s...

Full description

Bibliographic Details
Main Authors: Shenghua Liu, Haotian Chen, Zongtai Zheng, Yanyan He, Xudong Yao
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Bioengineering
Subjects:
bladder cancer
molecular subtype
immune
prognostic signature
MRI
radiomics
Online Access:https://www.mdpi.com/2306-5354/10/3/318

Internet

https://www.mdpi.com/2306-5354/10/3/318

Similar Items